Evaluation of Homobivalent Carbolines as Designed Multiple Ligands for the Treatment of Neurodegenerative Disorders

Author:

Otto Robert1,Penzis Robert2,Gaube Friedemann2,Adolph Oliver3,Föhr Karl J.3,Warncke Paul1,Robaa Dina4,Appenroth Dorothea5,Fleck Christian5,Enzensperger Christoph6,Lehmann Jochen1,Winckler Thomas2

Affiliation:

1. Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, University of Jena, Philosophenweg 14, 07743 Jena, Germany

2. Department of Pharmaceutical Biology, Institute of Pharmacy, University of Jena, Semmelweisstrasse 10, 07743 Jena, Germany

3. Department of Anesthesiology, University Hospital of Ulm, Albert-Einstein-Allee 23, 89081 Ulm, Germany

4. Institute of Pharmacy, Martin Luther University Halle-Wittenberg, Wolfgang-Langenbeck-Strasse 4, 06120 Halle/Saale, Germany

5. Institute of Pharmacology and Toxicology, University of Jena, Drackendorfer Strasse 1, 07747 Jena, Germany

6. Institute of Organic and Macromolecular Chemistry, Univerity of Jena, Humboldtstrasse 10, 07743 Jena, Germany

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3